Skip to content
Catalyst

3beta-hydroxyandrost-5-en-17-oneFinding

3beta-hydroxyandrost‑5-en‑17-one decreases triglycerides

lowersModerate evidenceFinding

01 · The sentence it was drawn from

“DHEA replacement resulted in a significant decrease in plasma triglycerides (DHEA: 120±10 mg/dl to 105±8 mg/dl; Placebo: 103±8 mg/dl to 110±8 mg/dl; p<0.05 within DHEA group; p<0.05 between groups).”
Quoted verbatim from Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.
This finding among the 118 findings on its endpoint

3beta-hydroxyandrost-5-en-17-one

Triglycerides

lowers

Who
men and women aged 65-75 without known diabetes; multivitamin and calcium/vitamin D supplements given to both arms
Dose studied
50 mg DHEA once daily for 12 months

Moderate evidencePMID 21566261 · 2011

02 · The study

Study
RCT
Duration
12 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7GY9SBPWDBJ403TQGAMHDMM